These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 30250162)

  • 1. Enrichment of gut-derived Fusobacterium is associated with suboptimal immune recovery in HIV-infected individuals.
    Lee SC; Chua LL; Yap SH; Khang TF; Leng CY; Raja Azwa RI; Lewin SR; Kamarulzaman A; Woo YL; Lim YAL; Loke P; Rajasuriar R
    Sci Rep; 2018 Sep; 8(1):14277. PubMed ID: 30250162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered gut microbiota correlate with different immune responses to HAART in HIV-infected individuals.
    Xie Y; Sun J; Wei L; Jiang H; Hu C; Yang J; Huang Y; Ruan B; Zhu B
    BMC Microbiol; 2021 Jan; 21(1):11. PubMed ID: 33407128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between CD4
    Lu D; Zhang JB; Wang YX; Geng ST; Zhang Z; Xu Y; Li SY; Wang KH; Kuang YQ
    BMC Infect Dis; 2021 Aug; 21(1):742. PubMed ID: 34344350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired gut junctional complexes feature late-treated individuals with suboptimal CD4+ T-cell recovery upon virologically suppressive combination antiretroviral therapy.
    Tincati C; Merlini E; Braidotti P; Ancona G; Savi F; Tosi D; Borghi E; Callegari ML; Mangiavillano B; Barassi A; Bulfamante G; d'Arminio Monforte A; Romagnoli S; Chomont N; Marchetti G
    AIDS; 2016 Apr; 30(7):991-1003. PubMed ID: 27028142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High T-cell immune activation and immune exhaustion among individuals with suboptimal CD4 recovery after 4 years of antiretroviral therapy in an African cohort.
    Nakanjako D; Ssewanyana I; Mayanja-Kizza H; Kiragga A; Colebunders R; Manabe YC; Nabatanzi R; Kamya MR; Cao H
    BMC Infect Dis; 2011 Feb; 11():43. PubMed ID: 21299909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid CD4 decline prior to antiretroviral therapy predicts subsequent failure to reconstitute despite HIV viral suppression.
    Darraj M; Shafer LA; Chan S; Kasper K; Keynan Y
    J Infect Public Health; 2018; 11(2):265-269. PubMed ID: 28826735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unique Gut Microbiome in HIV Patients on Antiretroviral Therapy (ART) Suggests Association with Chronic Inflammation.
    Ishizaka A; Koga M; Mizutani T; Parbie PK; Prawisuda D; Yusa N; Sedohara A; Kikuchi T; Ikeuchi K; Adachi E; Koibuchi T; Furukawa Y; Tojo A; Imoto S; Suzuki Y; Tsutsumi T; Kiyono H; Matano T; Yotsuyanagi H
    Microbiol Spectr; 2021 Sep; 9(1):e0070821. PubMed ID: 34378948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of chloroquine as a modulator of immune activation to improve CD4 recovery in immune nonresponding HIV-infected patients receiving antiretroviral therapy.
    Routy JP; Angel JB; Patel M; Kanagaratham C; Radzioch D; Kema I; Gilmore N; Ancuta P; Singer J; Jenabian MA
    HIV Med; 2015 Jan; 16(1):48-56. PubMed ID: 24889179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Composition of Gut Microbiota of Children and Adolescents With Perinatal Human Immunodeficiency Virus Infection Taking Antiretroviral Therapy in Zimbabwe.
    Flygel TT; Sovershaeva E; Claassen-Weitz S; Hjerde E; Mwaikono KS; Odland JØ; Ferrand RA; Mchugh G; Gutteberg TJ; Nicol MP; Cavanagh JP; Flægstad T;
    J Infect Dis; 2020 Jan; 221(3):483-492. PubMed ID: 31549151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determinants of CD4+ T cell recovery during suppressive antiretroviral therapy: association of immune activation, T cell maturation markers, and cellular HIV-1 DNA.
    Goicoechea M; Smith DM; Liu L; May S; Tenorio AR; Ignacio CC; Landay A; Haubrich R
    J Infect Dis; 2006 Jul; 194(1):29-37. PubMed ID: 16741879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variation in blood microbial lipopolysaccharide (LPS) contributes to immune reconstitution in response to suppressive antiretroviral therapy in HIV.
    Luo Z; Health SL; Li M; Yang H; Wu Y; Collins M; Deeks SG; Martin JN; Scott A; Jiang W
    EBioMedicine; 2022 Jun; 80():104037. PubMed ID: 35500539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Robust Reconstitution of Tuberculosis-Specific Polyfunctional CD4+ T-Cell Responses and Rising Systemic Interleukin 6 in Paradoxical Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome.
    Ravimohan S; Tamuhla N; Nfanyana K; Steenhoff AP; Letlhogile R; Frank I; MacGregor RR; Gross R; Weissman D; Bisson GP
    Clin Infect Dis; 2016 Mar; 62(6):795-803. PubMed ID: 26611774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral Microbiome in HIV-Infected Women: Shifts in the Abundance of Pathogenic and Beneficial Bacteria Are Associated with Aging, HIV Load, CD4 Count, and Antiretroviral Therapy.
    Lewy T; Hong BY; Weiser B; Burger H; Tremain A; Weinstock G; Anastos K; George MD
    AIDS Res Hum Retroviruses; 2019 Mar; 35(3):276-286. PubMed ID: 29808701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological determinants of immune reconstitution in HIV-infected patients receiving antiretroviral therapy: the role of interleukin 7 and interleukin 7 receptor α and microbial translocation.
    Rajasuriar R; Booth D; Solomon A; Chua K; Spelman T; Gouillou M; Schlub TE; Davenport M; Crowe S; Elliott J; Hoy J; Fairley C; Stewart G; Cameron P; Lewin SR
    J Infect Dis; 2010 Oct; 202(8):1254-64. PubMed ID: 20812848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activated dendritic cells and monocytes in HIV immunological nonresponders: HIV-induced interferon-inducible protein-10 correlates with low future CD4+ recovery.
    Stiksrud B; Aass HCD; Lorvik KB; Ueland T; Trøseid M; Dyrhol-Riise AM
    AIDS; 2019 Jun; 33(7):1117-1129. PubMed ID: 30789356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virologic and immunologic effects of adding maraviroc to suppressive antiretroviral therapy in individuals with suboptimal CD4+ T-cell recovery.
    Cillo AR; Hilldorfer BB; Lalama CM; McKinnon JE; Coombs RW; Tenorio AR; Fox L; Gandhi RT; Ribaudo H; Currier JS; Gulick RM; Wilkin TJ; Mellors JW
    AIDS; 2015 Oct; 29(16):2121-9. PubMed ID: 26544577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered Immunity and Microbial Dysbiosis in Aged Individuals With Long-Term Controlled HIV Infection.
    Rhoades N; Mendoza N; Jankeel A; Sureshchandra S; Alvarez AD; Doratt B; Heidari O; Hagan R; Brown B; Scheibel S; Marbley T; Taylor J; Messaoudi I
    Front Immunol; 2019; 10():463. PubMed ID: 30915086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atorvastatin reduces T-cell activation and exhaustion among HIV-infected cART-treated suboptimal immune responders in Uganda: a randomised crossover placebo-controlled trial.
    Nakanjako D; Ssinabulya I; Nabatanzi R; Bayigga L; Kiragga A; Joloba M; Kaleebu P; Kambugu AD; Kamya MR; Sekaly R; Elliott A; Mayanja-Kizza H
    Trop Med Int Health; 2015 Mar; 20(3):380-90. PubMed ID: 25441397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut Bacteria Metabolism Impacts Immune Recovery in HIV-infected Individuals.
    Serrano-Villar S; Rojo D; Martínez-Martínez M; Deusch S; Vázquez-Castellanos JF; Bargiela R; Sainz T; Vera M; Moreno S; Estrada V; Gosalbes MJ; Latorre A; Seifert J; Barbas C; Moya A; Ferrer M
    EBioMedicine; 2016 Jun; 8():203-216. PubMed ID: 27428431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased Natural Killer Cell Activation in HIV-Infected Immunologic Non-Responders Correlates with CD4+ T Cell Recovery after Antiretroviral Therapy and Viral Suppression.
    Luo Z; Li Z; Martin L; Hu Z; Wu H; Wan Z; Kilby M; Heath SL; Huang L; Jiang W
    PLoS One; 2017; 12(1):e0167640. PubMed ID: 28076376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.